Ally Financial’s iShares Biotechnology ETF IBB Stock Holding History

Ally Financial’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20,000	Closed	-$3.27M	–	123
2021 Q2	$3.27M	Buy	+20,000	New	+$3.08M	0.33%	74
2019 Q4	–	Sell	-50,000	Closed	-$4.97M	–	121
2019 Q3	$4.97M	Hold	50,000	–	–	0.88%	34
2019 Q2	$5.46M	Hold	50,000	–	–	0.94%	27
2019 Q1	$5.59M	Buy	50,000 +5,000	+11%	+$548K	1.07%	27
2018 Q4	$4.34M	Buy	45,000 +5,000	+13%	+$531K	0.57%	34
2018 Q3	$4.88M	Sell	40,000 -45,000	-53%	-$5.3M	0.97%	32
2018 Q2	$9.34M	Hold	85,000	–	–	1.83%	13
2018 Q1	$9.07M	Buy	85,000 +50,000	+143%	+$5.54M	1.36%	21
2017 Q4	$3.74M	Buy	+35,000	New	+$3.74M	0.72%	42
2017 Q3	–	Sell	-45,000	Closed	-$4.65M	–	117
2017 Q2	$4.65M	Buy	+45,000	New	+$4.43M	0.92%	39
2016 Q4	–	Sell	-30,000	Closed	-$2.9M	–	113
2016 Q3	$2.9M	Sell	30,000 -30,000	-50%	-$2.85M	0.51%	50
2016 Q2	$5.15M	Buy	60,000 +15,000	+33%	+$1.35M	0.86%	33
2016 Q1	$3.91M	Buy	+45,000	New	+$4.02M	0.55%	56
2014 Q2	–	Sell	-33,000	Closed	-$2.6M	–	135
2014 Q1	$2.6M	Buy	+33,000	New	+$2.75M	0.28%	117

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Ally Financial's IBB Position: Q3 2021 in Review

Ally Financial sold out of iShares Biotechnology ETF (IBB) in Q3 2021, closing a stake of 20,000 shares — an estimated $3.27M sold.

Ally Financial first reported a position in IBB in Q1 2014 and held it in 14 quarters. The position peaked at $9.34M in Q2 2018. 855 funds tracked by Wall St. Rank hold IBB as of Q3 2021.

Ally Financial reported no remaining iShares Biotechnology ETF position as of Q3 2021 after selling out during the quarter.
Ally Financial sold 20,000 iShares Biotechnology ETF shares in Q3 2021, an estimated $3.27M.
Ally Financial first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 14 quarters.
Ally Financial's iShares Biotechnology ETF position peaked at $9.34M in Q2 2018.
855 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2021.

Based on Ally Financial's 13F filing for Q3 2021, filed 10 Nov 2021.